Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Stemgenics
AddedFeb 16, 2024
UpdatedJun 18, 2026
Stemgenics

Stemgenics

Angel

Stemgenics develops technology to convert mature skin cells into personalized stem cells for tissue regeneration.

HQ
Seattle, WA, US
Founded
2008
Overview
Compare
Fundraising
Employees
Website

Stemgenics, founded with a mission to revolutionize regenerative medicine, focuses on developing technology that converts mature skin cells into personalized stem cells. These stem cells can potentially regenerate any tissue in the human body, offering groundbreaking solutions for various medical conditions. The company leverages a proprietary platform involving non-integrating multi-functionalized activated nanoparticles (NIMFA-NP) to deliver bioactive molecules into cells, tissues, and organs, aiming to advance therapeutic drug development.

Notable figures associated with Stemgenics include leading scientists and innovators in the field of nanotherapeutics and regenerative medicine. The company has secured investments from prominent venture capital firms specializing in biotech innovations. Key achievements include the successful development and patenting of their NIMFA-NP technology, which has broad applications in therapeutic drug development. Stemgenics' impact lies in its potential to transform personalized medicine and tissue regeneration, offering hope for treatments of previously incurable conditions.

Stemgenics - Similar Companies

ImStem Biotechnology logo

ImStem Biotechnology

imstem.com

APstem Therapeutics logo

APstem Therapeutics

apstemtx.com

Stemson Therapeutics logo

Stemson Therapeutics

stemsontx.com

Stemcyte logo

Stemcyte

stemcyte.com

NovelStem International logo

NovelStem International

novelstem.com

Cellebration Life Sciences logo

Cellebration Life Sciences

Regenerative Medical Solutions logo

Regenerative Medical Solutions

Personal Cell Sciences logo

Personal Cell Sciences

InGeneron logo

InGeneron

ingeneron.com

DiscGenics logo

DiscGenics

discgenics.com

Spheringenics logo

Spheringenics

Ankasa Regenerative Therapeutics logo

Ankasa Regenerative Therapeutics

Cellino logo

Cellino

cellinobio.com

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Personalized Stem Cells logo

Personalized Stem Cells

Stemgenics - Quick Facts

Who are Stemgenics' competitors?

Companies similar to Stemgenics include ImStem Biotechnology, APstem Therapeutics, Stemson Therapeutics and Stemcyte.

When was Stemgenics founded?

Stemgenics was founded in 2008.

Where is Stemgenics' headquarters located?

Stemgenics' headquarters is located in Seattle, WA, US.

When was Stemgenics' last funding round?

Stemgenics' most recent funding round was for $445k (USD) in June 2018.

How much has Stemgenics raised to-date?

As of Jun 20, 2018, Stemgenics has raised a total of $3.5M (USD).

How many employees does Stemgenics have?

Stemgenics has 3 employees as of Feb 5, 2024.

Stemgenics - Classification

Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Stem Cells
  • Therapeutics
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified